A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRX) Administered to Adults With Familial Chylomicronemia Syndrome (FCS) Previously Treated With Volanesorsen

University of Rochester School of Medicine, Rochester

Excel Medical Clinical Trials, LLC, Boca Raton

Diabetes/Lipid Management & Research Center, Huntington Beach

University of Michigan, Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes (MEND), Ann Arbor

Centre for Heart Lung Innovation, Vancouver

ARC Biosystems, Clinical Assessment Unit (CAU), Vancouver

St. Boniface General Hospital, Winnipeg

Ecogene-21, Chicoutimi

Clinique des Maladies Lipidiques de Quebec Inc., Québec

Centre Hospitalier Universite de Sherbrooke (CHUS), Sherbrooke

Karolinska University Hospital Huddinge, Stockholm